J0153Adenosine inj 1mg
Published CMS Medicare Part B payment-limit context for J0153, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$0.394
per 1 MG · Medicare Part B
Down 17.9%from $0.48 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$0.5885$0.2825
2024-Q4: $0.397; 2025-Q1: $0.316; 2025-Q2: $0.386; 2025-Q3: $0.456; 2025-Q4: $0.555; 2026-Q1: $0.529; 2026-Q2: $0.48; 2026-Q3: $0.394
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Adenosine ingredient family (FDA data as of August 20, 2026).
Adenosine
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.